We are live on
!
Find out more
DA
DCF Advisers Portfolio holdings
AUM
$375M
1-Year Est. Return
72.65%
This Fund
S&P 500
This Quarter
Est. Return
+14.91%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$242M
AUM Growth
+$46.8M
(+24%)
Cap. Flow
+$26.1M
Cap. Flow
% of AUM
10.78%
Top 10 Holdings %
Top 10 Hldgs %
46.63%
Holding
110
New
24
Increased
21
Reduced
24
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Becton Dickinson
BDX
|
+$2.39M |
| 2 |
Alibaba
BABA
|
+$1.94M |
| 3 |
Gilead Sciences
GILD
|
+$1.72M |
| 4 |
AbbVie
ABBV
|
+$1.63M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$1.43M |
| 2 |
iShares Biotechnology ETF
IBB
|
+$1.35M |
| 3 |
Cisco
CSCO
|
+$1.18M |
| 4 |
Verizon
VZ
|
+$1.14M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$1.04M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.28% |
| 2 | Technology | 13.29% |
| 3 | Communication Services | 7.57% |
| 4 | Financials | 4.7% |
| 5 | Consumer Discretionary | 2.76% |
Similar funds
JIC
CIM
AIM
MWM
RCP
HPM
CAG
LWMNY
DCF Advisers's Q4 2020 Portfolio in Review
As of Q4 2020, DCF Advisers held 110 positions worth $242M, up 24% from $196M the previous quarter. Its ten largest holdings account for 47% of the portfolio.
DCF Advisers deployed $26.1M of net new capital in Q4 2020, opening 24 new positions and adding to 21 existing holdings. Its largest new stake was Becton Dickinson: 10,250 shares worth $2.5M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, down from 35% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $1.43M trimmed.
- DCF Advisers's largest Q4 2020 buy was Becton Dickinson: 10,250 shares worth $2.5M.
- DCF Advisers added most to AbbVie in Q4 2020, an estimated $1.63M increase.
- DCF Advisers's biggest Q4 2020 reduction was Alphabet (Google) Class C, cutting an estimated $1.43M.
- DCF Advisers fully exited iShares Biotechnology ETF in Q4 2020, selling an estimated $1.35M.
- DCF Advisers's ten largest holdings make up 47% of its $242M portfolio in Q4 2020.
- DCF Advisers opened 24 new positions and closed 20 in Q4 2020.
- DCF Advisers's portfolio value rose 24% quarter-over-quarter to $242M.
Based on DCF Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.